Close
  Indian J Med Microbiol
 

Figure 4: Changes in total lesion count in Groups A (nadifloxacin and benzoyl peroxide) and B (adapalene and benzoyl peroxide). Total lesion count (mean ± standard deviation) in Group A are 22.06 ± 0.9, 13.29 ± 0.6, 7.82 ± 0.4, 3.7 ± 0.3 at weeks 0, 4, 8, and 12, respectively; in Group B are 23.12 ± 0.9, 8.88 ± 0.8, 3.29 ± 0.3, 1.17 ± 0.2 at weeks 0,4, 8, and 12, respectively. *P< 0.05 and **P < 0.05-weeks 4, 8, and 12 versus week 0 in Groups A and B respectively. Intergroup comparison of total lesion count levels at weeks 4, 8, and 12: $P< 0.05 - Group A versus B at week 4. #P< 0.05 - Group A versus B at week 8. ##P< 0.05 - Group A versus B at week 12

Figure 4: Changes in total lesion count in Groups A (nadifloxacin and benzoyl peroxide) and B (adapalene and benzoyl peroxide). Total lesion count (mean ± standard deviation) in Group A are 22.06 ± 0.9, 13.29 ± 0.6, 7.82 ± 0.4, 3.7 ± 0.3 at weeks 0, 4, 8, and 12, respectively; in Group B are 23.12 ± 0.9, 8.88 ± 0.8, 3.29 ± 0.3, 1.17 ± 0.2 at weeks 0,4, 8, and 12, respectively. *<i>P</i>< 0.05 and **P < 0.05-weeks 4, 8, and 12 versus week 0 in Groups A and B respectively. Intergroup comparison of total lesion count levels at weeks 4, 8, and 12: <sup>$</sup><i>P</i>< 0.05 - Group A versus B at week 4. <sup>#</sup><i>P</i>< 0.05 - Group A versus B at week 8. <sup>##</sup><i>P</i>< 0.05 - Group A versus B at week 12